Literature DB >> 16088148

Consensus statement on the safety profile of topical calcineurin inhibitors.

T Bieber, M Cork, C Ellis, G Girolomoni, R Groves, R Langley, T Luger, M Meurer, D Murrell, S Orlow, A Paller, Y de Prost, L Puig, J Ring, J-H Saurat, T Schwarz, N Shear, G Stingl, A Taieb, K Thestrup-Pedersen.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16088148     DOI： 10.1159/000086431

Source DB:  PubMed          Journal:  Dermatology        ISSN： 1018-8665            Impact factor:   5.366


× No keyword cloud information.
  11 in total

1.  Atopic dermatitis.

Authors:  Thomas Bieber
Journal:  Ann Dermatol       Date:  2010-05-17       Impact factor: 1.444

2.  [Vaccinations with atopic dermatitis and other chronic inflammatory skin diseases].

Authors:  A Wollenberg; S Vogel; E D Renner
Journal:  Hautarzt       Date:  2010-11       Impact factor: 0.751

Review 3.  Topical calcineurin inhibitors and lymphoma risk: evidence update with implications for daily practice.

Authors:  Elaine C Siegfried; Jennifer C Jaworski; Adelaide A Hebert
Journal:  Am J Clin Dermatol       Date:  2013-06       Impact factor: 7.403

Review 4.  Topical calcineurin inhibitors in pediatric atopic dermatitis: a critical analysis of current issues.

Authors:  Seth J Orlow
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

Review 5.  A safety assessment of topical calcineurin inhibitors in the treatment of atopic dermatitis.

Authors:  Mark Lebwohl; Tara Gower
Journal:  MedGenMed       Date:  2006-10-10

Review 6.  Atopic eczema.

Authors:  Matthias Möhrenschlager; Johannes Ring
Journal:  Curr Allergy Asthma Rep       Date:  2006-11       Impact factor: 4.919

7.  Current and emerging therapy for the management of vitiligo.

Authors:  Alicia Cecile Borderé; Jo Lambert; Nanny van Geel
Journal:  Clin Cosmet Investig Dermatol       Date:  2009-03-12

8.  Atopic dermatitis and the atopic march: what is new?

Authors:  Annalisa Patrizi; Alessandro Pileri; Federica Bellini; Beatrice Raone; Iria Neri; Giampaolo Ricci
Journal:  J Allergy (Cairo)       Date:  2011-09-13

9.  CSACI position statement: safety of topical calcineurin inhibitors in the management of atopic dermatitis in children and adults.

Authors:  Audrey O Segal; Anne K Ellis; Harold L Kim
Journal:  Allergy Asthma Clin Immunol       Date:  2013-07-09       Impact factor: 3.406

Review 10.  Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants.

Authors:  Thomas Luger; Mark Boguniewicz; Warner Carr; Michael Cork; Mette Deleuran; Lawrence Eichenfield; Philippe Eigenmann; Regina Fölster-Holst; Carlo Gelmetti; Harald Gollnick; Eckard Hamelmann; Adelaide A Hebert; Antonella Muraro; Arnold P Oranje; Amy S Paller; Carle Paul; Luis Puig; Johannes Ring; Elaine Siegfried; Jonathan M Spergel; Georg Stingl; Alain Taieb; Antonio Torrelo; Thomas Werfel; Ulrich Wahn
Journal:  Pediatr Allergy Immunol       Date:  2015-04-13       Impact factor: 6.377
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.